% Expired Patents = 100.0

Forward Citations = 26

Loading Chart...

6 inventors (with patents filed for the assignee):

Alexander A Gall (7 out of 47 patents)

Richard Daifuku (7 out of 11 patents)

Dmitri S Sergueev (5 out of 7 patents)

4. Dina Sologub (4 out of 4 patents)

5. Kevin Harris (4 out of 4 patents)

6. Ling Li (2 out of 2 patents)

7 patents: Sort by Forward Citations

1. 8324379 - Prodrugs of heteroaryl compounds (2012-12-04),

2. 7982034 - Prodrugs of heteroaryl compounds (2011-07-19),

3. 7648967 - Mutagenic nucleoside analogs for the treatment of viral disease (2010-01-19),

4. 7642247 - 1,3,5-triazines for treatment of viral diseases (2010-01-05),

5. 7589092 - Prodrugs of heteroaryl compounds (2009-09-15),

6. 7244732 - Prodrugs of heteroaryl compounds (2007-07-17),

7. 7244717 - Mutagenic nucleoside analogs for the treatment of viral disease (2007-07-17),

Company Overview

Koronis Pharmaceuticals, Inc. is a biotechnology company dedicated to developing novel antiviral therapeutics to address unmet medical needs. With a focus on respiratory infections, including influenza and COVID-19, Koronis aims to provide innovative solutions to combat viral diseases. The company leverages cutting-edge research and technology to accelerate the development of safe and effective treatments for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#69 in Redmond, WA

#927 in Washington

#39,879 in US

Redmond, WA, United States of America

Koronis Pharmaceuticals, Inc.

Forward Citations = 26

6 inventors:

Alexander A Gall (7 out of 47 patents)

Richard Daifuku (7 out of 11 patents)

Dmitri S Sergueev (5 out of 7 patents)

4. Dina Sologub (4 out of 4 patents)

5. Kevin Harris (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Koronis Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/koronis-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]